Biol Reprod Keystone Symposia Conference on Frontiers in Reproductive Biology & Regulation of Fertility.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ANDERSON, D. J.
Right arrow Articles by ALEXANDER, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ANDERSON, D. J.
Right arrow Articles by ALEXANDER, N. J.
Agricola
Right arrow Articles by ANDERSON, D. J.
Right arrow Articles by ALEXANDER, N. J.

Biology of Reproduction, Vol 21, 1143-1152, Copyright © 1979 by Society for the Study of Reproduction

Induction of Uterine Leukocytosis and Its Effect on Pregnancy in Rats

DEBORAH J. ANDERSON 1, and NANCY J. ALEXANDER 1

1 Reproductive Physiology, Oregon Regional Primate Research Center, Beaverton, Oregon 97006


Glycogen, a leukocyte chemotactic agent, was used to induce transient leukocytosis in rat uteri during pregnancy. Large numbers of polymorphonuclear leukocytes (PMNLs) were attracted to the uterine endometrium and lumen after a single intrauterine injection of soluble glycogen (ligated horns) or glycogen-releasing gelatin beads (nonligated horns). Glycogen treatment on Days 3 through 5 of pregnancy (Day 5 = implantation) caused complete termination of pregnancy and significantly reduced fertility on Days 2 and 6 of pregnancy. However, fertility was unaffected by glycogen treatment after Day 6 of pregnancy even though a substantial leukocytic response was also elicited by glycogen in rats during later stages of gestation. This study indicates that glycogeninduced uterine leukocytosis effectively terminates pregnancy before and during the implantation stage. We propose that leukocyte chemotactic agents such as glycogen may prove clinically useful as abortifacient agents or may be used to improve the contraceptive efficiency of intrauterine devces.

Note:
ACKNOWLEDGMENTS The research reported in this article, Publication No. 1058 of the Oregon Regional Primate Research Center, was supported by the Program for Applied Research on Fertility Regulation, Northwestern University, under contract AID/csd-3608. The authors wish to thank Mary Boudreaux and Belinda Toyooka for excellent technical assistance and Patsy Kimzey for helping with the preparation of this manuscript.

Submitted on February 19, 1979
Accepted on September 14, 1979







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the Society for the Study of Reproduction.